Bausch Health Companies Inc. (TSE:BHC) to Post Q3 2025 Earnings of $1.41 Per Share, Zacks Research Forecasts

Bausch Health Companies Inc. (TSE:BHCFree Report) – Zacks Research decreased their Q3 2025 earnings per share estimates for Bausch Health Companies in a report released on Monday, February 5th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $1.41 for the quarter, down from their prior estimate of $1.46. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.21 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q4 2025 earnings at $1.77 EPS.

Separately, Royal Bank of Canada lowered their target price on Bausch Health Companies from C$9.00 to C$8.00 and set a “sector perform” rating for the company in a research note on Monday, October 23rd.

Get Our Latest Report on BHC

Bausch Health Companies Stock Down 0.2 %

TSE BHC opened at C$10.93 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 1.20 and a debt-to-equity ratio of 7,583.76. Bausch Health Companies has a fifty-two week low of C$7.56 and a fifty-two week high of C$13.81. The business has a 50 day moving average price of C$10.53 and a two-hundred day moving average price of C$10.71. The stock has a market cap of C$3.99 billion, a PE ratio of -3.07, a P/E/G ratio of 0.21 and a beta of 0.90.

About Bausch Health Companies

(Get Free Report)

Bausch Health Companies Inc operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

Recommended Stories

Earnings History and Estimates for Bausch Health Companies (TSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with's FREE daily email newsletter.